nodes	percent_of_prediction	percent_of_DWPC	metapath
Prazosin—SLC22A2—Cisplatin—bone cancer	0.195	0.238	CbGbCtD
Prazosin—ABCG2—Carboplatin—bone cancer	0.168	0.206	CbGbCtD
Prazosin—ABCG2—Cisplatin—bone cancer	0.144	0.176	CbGbCtD
Prazosin—ABCG2—Doxorubicin—bone cancer	0.0964	0.118	CbGbCtD
Prazosin—ABCG2—Methotrexate—bone cancer	0.0934	0.114	CbGbCtD
Prazosin—ABCB1—Cisplatin—bone cancer	0.0519	0.0635	CbGbCtD
Prazosin—ABCB1—Doxorubicin—bone cancer	0.0348	0.0425	CbGbCtD
Prazosin—ABCB1—Methotrexate—bone cancer	0.0337	0.0412	CbGbCtD
Prazosin—HTR1D—dura mater—bone cancer	0.0122	0.371	CbGeAlD
Prazosin—HTR1D—trigeminal nerve—bone cancer	0.00523	0.16	CbGeAlD
Prazosin—Alfuzosin—CYP3A4—bone cancer	0.0045	1	CrCbGaD
Prazosin—ORM1—vertebral column—bone cancer	0.00403	0.123	CbGeAlD
Prazosin—HTR1D—cranial nerve—bone cancer	0.00373	0.114	CbGeAlD
Prazosin—Retinal disorder—Methotrexate—bone cancer	0.00194	0.0381	CcSEcCtD
Prazosin—MT3—spinal cord—bone cancer	0.00173	0.0527	CbGeAlD
Prazosin—Pain—Carboplatin—bone cancer	0.00132	0.0258	CcSEcCtD
Prazosin—Body temperature increased—Carboplatin—bone cancer	0.00122	0.0238	CcSEcCtD
Prazosin—Nasal congestion—Cisplatin—bone cancer	0.00101	0.0197	CcSEcCtD
Prazosin—Orthostatic hypotension—Cisplatin—bone cancer	0.000838	0.0164	CcSEcCtD
Prazosin—Pancreatitis—Cisplatin—bone cancer	0.000778	0.0152	CcSEcCtD
Prazosin—Sweating increased—Cisplatin—bone cancer	0.000773	0.0151	CcSEcCtD
Prazosin—HTR1D—connective tissue—bone cancer	0.000769	0.0235	CbGeAlD
Prazosin—Abdominal discomfort—Cisplatin—bone cancer	0.00076	0.0149	CcSEcCtD
Prazosin—SLC22A3—connective tissue—bone cancer	0.000742	0.0226	CbGeAlD
Prazosin—Vasculitis—Methotrexate—bone cancer	0.000711	0.0139	CcSEcCtD
Prazosin—Bradycardia—Cisplatin—bone cancer	0.000646	0.0127	CcSEcCtD
Prazosin—Gynaecomastia—Methotrexate—bone cancer	0.000621	0.0122	CcSEcCtD
Prazosin—Tinnitus—Cisplatin—bone cancer	0.000592	0.0116	CcSEcCtD
Prazosin—Flushing—Cisplatin—bone cancer	0.000589	0.0116	CcSEcCtD
Prazosin—ORM1—bone marrow—bone cancer	0.000564	0.0172	CbGeAlD
Prazosin—ORM1—spinal cord—bone cancer	0.000562	0.0171	CbGeAlD
Prazosin—Alopecia—Cisplatin—bone cancer	0.000561	0.011	CcSEcCtD
Prazosin—Eye pain—Epirubicin—bone cancer	0.000522	0.0102	CcSEcCtD
Prazosin—Vision blurred—Cisplatin—bone cancer	0.000521	0.0102	CcSEcCtD
Prazosin—Ill-defined disorder—Cisplatin—bone cancer	0.000513	0.0101	CcSEcCtD
Prazosin—Malaise—Cisplatin—bone cancer	0.000498	0.00977	CcSEcCtD
Prazosin—Eye pain—Doxorubicin—bone cancer	0.000483	0.00947	CcSEcCtD
Prazosin—Discomfort—Cisplatin—bone cancer	0.000465	0.00911	CcSEcCtD
Prazosin—Oedema—Cisplatin—bone cancer	0.000451	0.00884	CcSEcCtD
Prazosin—ADRA2A—connective tissue—bone cancer	0.000449	0.0137	CbGeAlD
Prazosin—Tachycardia—Cisplatin—bone cancer	0.00044	0.00863	CcSEcCtD
Prazosin—Hyperhidrosis—Cisplatin—bone cancer	0.000436	0.00855	CcSEcCtD
Prazosin—Orthostatic hypotension—Epirubicin—bone cancer	0.00043	0.00844	CcSEcCtD
Prazosin—Pancreatitis—Methotrexate—bone cancer	0.000427	0.00837	CcSEcCtD
Prazosin—HTR1A—spinal cord—bone cancer	0.000425	0.013	CbGeAlD
Prazosin—Abdominal discomfort—Methotrexate—bone cancer	0.000417	0.00818	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000411	0.00806	CcSEcCtD
Prazosin—Paraesthesia—Cisplatin—bone cancer	0.000405	0.00794	CcSEcCtD
Prazosin—Dyspnoea—Cisplatin—bone cancer	0.000402	0.00788	CcSEcCtD
Prazosin—Erectile dysfunction—Methotrexate—bone cancer	0.000401	0.00786	CcSEcCtD
Prazosin—Pancreatitis—Epirubicin—bone cancer	0.000399	0.00783	CcSEcCtD
Prazosin—Orthostatic hypotension—Doxorubicin—bone cancer	0.000398	0.00781	CcSEcCtD
Prazosin—Angina pectoris—Epirubicin—bone cancer	0.000397	0.00778	CcSEcCtD
Prazosin—Drowsiness—Methotrexate—bone cancer	0.000388	0.00761	CcSEcCtD
Prazosin—Pain—Cisplatin—bone cancer	0.000386	0.00756	CcSEcCtD
Prazosin—KCNH2—bone marrow—bone cancer	0.00038	0.0116	CbGeAlD
Prazosin—KCNH2—spinal cord—bone cancer	0.000378	0.0115	CbGeAlD
Prazosin—Pollakiuria—Epirubicin—bone cancer	0.000376	0.00738	CcSEcCtD
Prazosin—Feeling abnormal—Cisplatin—bone cancer	0.000372	0.00729	CcSEcCtD
Prazosin—Pancreatitis—Doxorubicin—bone cancer	0.00037	0.00724	CcSEcCtD
Prazosin—Angina pectoris—Doxorubicin—bone cancer	0.000367	0.0072	CcSEcCtD
Prazosin—Epistaxis—Methotrexate—bone cancer	0.000366	0.00718	CcSEcCtD
Prazosin—Drowsiness—Epirubicin—bone cancer	0.000363	0.00712	CcSEcCtD
Prazosin—Body temperature increased—Cisplatin—bone cancer	0.000357	0.00699	CcSEcCtD
Prazosin—Pollakiuria—Doxorubicin—bone cancer	0.000348	0.00683	CcSEcCtD
Prazosin—Epistaxis—Epirubicin—bone cancer	0.000343	0.00672	CcSEcCtD
Prazosin—ABCG2—bone marrow—bone cancer	0.000338	0.0103	CbGeAlD
Prazosin—ABCG2—spinal cord—bone cancer	0.000337	0.0103	CbGeAlD
Prazosin—Drowsiness—Doxorubicin—bone cancer	0.000336	0.00659	CcSEcCtD
Prazosin—Hypersensitivity—Cisplatin—bone cancer	0.000332	0.00651	CcSEcCtD
Prazosin—Bradycardia—Epirubicin—bone cancer	0.000332	0.00651	CcSEcCtD
Prazosin—Tinnitus—Methotrexate—bone cancer	0.000325	0.00637	CcSEcCtD
Prazosin—Asthenia—Cisplatin—bone cancer	0.000324	0.00634	CcSEcCtD
Prazosin—Epistaxis—Doxorubicin—bone cancer	0.000317	0.00621	CcSEcCtD
Prazosin—ADRA2A—tendon—bone cancer	0.000309	0.00942	CbGeAlD
Prazosin—Diarrhoea—Cisplatin—bone cancer	0.000309	0.00605	CcSEcCtD
Prazosin—Alopecia—Methotrexate—bone cancer	0.000308	0.00603	CcSEcCtD
Prazosin—Bradycardia—Doxorubicin—bone cancer	0.000307	0.00602	CcSEcCtD
Prazosin—Tinnitus—Epirubicin—bone cancer	0.000304	0.00596	CcSEcCtD
Prazosin—Flushing—Epirubicin—bone cancer	0.000303	0.00593	CcSEcCtD
Prazosin—ADRA2A—spinal cord—bone cancer	0.000298	0.00909	CbGeAlD
Prazosin—Alopecia—Epirubicin—bone cancer	0.000288	0.00565	CcSEcCtD
Prazosin—Vomiting—Cisplatin—bone cancer	0.000287	0.00562	CcSEcCtD
Prazosin—Vision blurred—Methotrexate—bone cancer	0.000286	0.0056	CcSEcCtD
Prazosin—Rash—Cisplatin—bone cancer	0.000284	0.00558	CcSEcCtD
Prazosin—Dermatitis—Cisplatin—bone cancer	0.000284	0.00557	CcSEcCtD
Prazosin—Ill-defined disorder—Methotrexate—bone cancer	0.000281	0.00552	CcSEcCtD
Prazosin—Tinnitus—Doxorubicin—bone cancer	0.000281	0.00551	CcSEcCtD
Prazosin—Flushing—Doxorubicin—bone cancer	0.00028	0.00549	CcSEcCtD
Prazosin—Tension—Epirubicin—bone cancer	0.000279	0.00546	CcSEcCtD
Prazosin—Nervousness—Epirubicin—bone cancer	0.000276	0.0054	CcSEcCtD
Prazosin—Malaise—Methotrexate—bone cancer	0.000274	0.00536	CcSEcCtD
Prazosin—Vertigo—Methotrexate—bone cancer	0.000273	0.00534	CcSEcCtD
Prazosin—Nausea—Cisplatin—bone cancer	0.000268	0.00525	CcSEcCtD
Prazosin—Vision blurred—Epirubicin—bone cancer	0.000268	0.00524	CcSEcCtD
Prazosin—Alopecia—Doxorubicin—bone cancer	0.000267	0.00523	CcSEcCtD
Prazosin—Ill-defined disorder—Epirubicin—bone cancer	0.000263	0.00516	CcSEcCtD
Prazosin—Arthralgia—Methotrexate—bone cancer	0.000258	0.00506	CcSEcCtD
Prazosin—Tension—Doxorubicin—bone cancer	0.000258	0.00505	CcSEcCtD
Prazosin—Malaise—Epirubicin—bone cancer	0.000256	0.00502	CcSEcCtD
Prazosin—Discomfort—Methotrexate—bone cancer	0.000255	0.005	CcSEcCtD
Prazosin—Nervousness—Doxorubicin—bone cancer	0.000255	0.005	CcSEcCtD
Prazosin—Vertigo—Epirubicin—bone cancer	0.000255	0.005	CcSEcCtD
Prazosin—Syncope—Epirubicin—bone cancer	0.000255	0.00499	CcSEcCtD
Prazosin—Palpitations—Epirubicin—bone cancer	0.000251	0.00492	CcSEcCtD
Prazosin—Loss of consciousness—Epirubicin—bone cancer	0.000249	0.00489	CcSEcCtD
Prazosin—Vision blurred—Doxorubicin—bone cancer	0.000248	0.00485	CcSEcCtD
Prazosin—Ill-defined disorder—Doxorubicin—bone cancer	0.000244	0.00478	CcSEcCtD
Prazosin—Arthralgia—Epirubicin—bone cancer	0.000242	0.00474	CcSEcCtD
Prazosin—Hyperhidrosis—Methotrexate—bone cancer	0.000239	0.00469	CcSEcCtD
Prazosin—Discomfort—Epirubicin—bone cancer	0.000239	0.00468	CcSEcCtD
Prazosin—Malaise—Doxorubicin—bone cancer	0.000237	0.00464	CcSEcCtD
Prazosin—Dry mouth—Epirubicin—bone cancer	0.000236	0.00463	CcSEcCtD
Prazosin—Vertigo—Doxorubicin—bone cancer	0.000236	0.00463	CcSEcCtD
Prazosin—Syncope—Doxorubicin—bone cancer	0.000236	0.00462	CcSEcCtD
Prazosin—Palpitations—Doxorubicin—bone cancer	0.000232	0.00455	CcSEcCtD
Prazosin—Oedema—Epirubicin—bone cancer	0.000232	0.00454	CcSEcCtD
Prazosin—Loss of consciousness—Doxorubicin—bone cancer	0.000231	0.00452	CcSEcCtD
Prazosin—Shock—Epirubicin—bone cancer	0.000228	0.00447	CcSEcCtD
Prazosin—Tachycardia—Epirubicin—bone cancer	0.000226	0.00443	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000226	0.00442	CcSEcCtD
Prazosin—Hyperhidrosis—Epirubicin—bone cancer	0.000224	0.00439	CcSEcCtD
Prazosin—Insomnia—Methotrexate—bone cancer	0.000224	0.00439	CcSEcCtD
Prazosin—Arthralgia—Doxorubicin—bone cancer	0.000224	0.00438	CcSEcCtD
Prazosin—Paraesthesia—Methotrexate—bone cancer	0.000222	0.00436	CcSEcCtD
Prazosin—Discomfort—Doxorubicin—bone cancer	0.000221	0.00433	CcSEcCtD
Prazosin—Dyspnoea—Methotrexate—bone cancer	0.000221	0.00433	CcSEcCtD
Prazosin—Somnolence—Methotrexate—bone cancer	0.00022	0.00431	CcSEcCtD
Prazosin—Dry mouth—Doxorubicin—bone cancer	0.000219	0.00429	CcSEcCtD
Prazosin—Oedema—Doxorubicin—bone cancer	0.000214	0.0042	CcSEcCtD
Prazosin—Fatigue—Methotrexate—bone cancer	0.000213	0.00418	CcSEcCtD
Prazosin—Pain—Methotrexate—bone cancer	0.000212	0.00415	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000211	0.00414	CcSEcCtD
Prazosin—Shock—Doxorubicin—bone cancer	0.000211	0.00413	CcSEcCtD
Prazosin—Insomnia—Epirubicin—bone cancer	0.00021	0.00411	CcSEcCtD
Prazosin—Tachycardia—Doxorubicin—bone cancer	0.000209	0.0041	CcSEcCtD
Prazosin—Paraesthesia—Epirubicin—bone cancer	0.000208	0.00408	CcSEcCtD
Prazosin—Hyperhidrosis—Doxorubicin—bone cancer	0.000207	0.00406	CcSEcCtD
Prazosin—Dyspnoea—Epirubicin—bone cancer	0.000207	0.00405	CcSEcCtD
Prazosin—Somnolence—Epirubicin—bone cancer	0.000206	0.00404	CcSEcCtD
Prazosin—Feeling abnormal—Methotrexate—bone cancer	0.000204	0.004	CcSEcCtD
Prazosin—Fatigue—Epirubicin—bone cancer	0.0002	0.00391	CcSEcCtD
Prazosin—Pain—Epirubicin—bone cancer	0.000198	0.00388	CcSEcCtD
Prazosin—Constipation—Epirubicin—bone cancer	0.000198	0.00388	CcSEcCtD
Prazosin—Urticaria—Methotrexate—bone cancer	0.000197	0.00385	CcSEcCtD
Prazosin—Body temperature increased—Methotrexate—bone cancer	0.000196	0.00384	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000195	0.00383	CcSEcCtD
Prazosin—Insomnia—Doxorubicin—bone cancer	0.000194	0.0038	CcSEcCtD
Prazosin—Paraesthesia—Doxorubicin—bone cancer	0.000192	0.00377	CcSEcCtD
Prazosin—Dyspnoea—Doxorubicin—bone cancer	0.000191	0.00375	CcSEcCtD
Prazosin—Feeling abnormal—Epirubicin—bone cancer	0.000191	0.00374	CcSEcCtD
Prazosin—Somnolence—Doxorubicin—bone cancer	0.000191	0.00374	CcSEcCtD
Prazosin—Fatigue—Doxorubicin—bone cancer	0.000185	0.00362	CcSEcCtD
Prazosin—Urticaria—Epirubicin—bone cancer	0.000184	0.00361	CcSEcCtD
Prazosin—Pain—Doxorubicin—bone cancer	0.000183	0.00359	CcSEcCtD
Prazosin—Constipation—Doxorubicin—bone cancer	0.000183	0.00359	CcSEcCtD
Prazosin—Body temperature increased—Epirubicin—bone cancer	0.000183	0.00359	CcSEcCtD
Prazosin—Hypersensitivity—Methotrexate—bone cancer	0.000182	0.00357	CcSEcCtD
Prazosin—Asthenia—Methotrexate—bone cancer	0.000178	0.00348	CcSEcCtD
Prazosin—Feeling abnormal—Doxorubicin—bone cancer	0.000177	0.00346	CcSEcCtD
Prazosin—Pruritus—Methotrexate—bone cancer	0.000175	0.00343	CcSEcCtD
Prazosin—Hypersensitivity—Epirubicin—bone cancer	0.000171	0.00335	CcSEcCtD
Prazosin—Urticaria—Doxorubicin—bone cancer	0.00017	0.00334	CcSEcCtD
Prazosin—Body temperature increased—Doxorubicin—bone cancer	0.000169	0.00332	CcSEcCtD
Prazosin—Diarrhoea—Methotrexate—bone cancer	0.000169	0.00332	CcSEcCtD
Prazosin—ABCB1—bone marrow—bone cancer	0.000167	0.00509	CbGeAlD
Prazosin—Asthenia—Epirubicin—bone cancer	0.000166	0.00326	CcSEcCtD
Prazosin—ABCB1—spinal cord—bone cancer	0.000166	0.00506	CbGeAlD
Prazosin—Pruritus—Epirubicin—bone cancer	0.000164	0.00321	CcSEcCtD
Prazosin—Dizziness—Methotrexate—bone cancer	0.000164	0.00321	CcSEcCtD
Prazosin—Diarrhoea—Epirubicin—bone cancer	0.000159	0.00311	CcSEcCtD
Prazosin—Hypersensitivity—Doxorubicin—bone cancer	0.000158	0.0031	CcSEcCtD
Prazosin—Vomiting—Methotrexate—bone cancer	0.000157	0.00309	CcSEcCtD
Prazosin—Rash—Methotrexate—bone cancer	0.000156	0.00306	CcSEcCtD
Prazosin—Dermatitis—Methotrexate—bone cancer	0.000156	0.00306	CcSEcCtD
Prazosin—Headache—Methotrexate—bone cancer	0.000155	0.00304	CcSEcCtD
Prazosin—Asthenia—Doxorubicin—bone cancer	0.000154	0.00301	CcSEcCtD
Prazosin—Dizziness—Epirubicin—bone cancer	0.000153	0.003	CcSEcCtD
Prazosin—Pruritus—Doxorubicin—bone cancer	0.000152	0.00297	CcSEcCtD
Prazosin—Vomiting—Epirubicin—bone cancer	0.000147	0.00289	CcSEcCtD
Prazosin—Nausea—Methotrexate—bone cancer	0.000147	0.00288	CcSEcCtD
Prazosin—Diarrhoea—Doxorubicin—bone cancer	0.000147	0.00287	CcSEcCtD
Prazosin—Rash—Epirubicin—bone cancer	0.000146	0.00286	CcSEcCtD
Prazosin—Dermatitis—Epirubicin—bone cancer	0.000146	0.00286	CcSEcCtD
Prazosin—Headache—Epirubicin—bone cancer	0.000145	0.00284	CcSEcCtD
Prazosin—Dizziness—Doxorubicin—bone cancer	0.000142	0.00278	CcSEcCtD
Prazosin—Nausea—Epirubicin—bone cancer	0.000138	0.0027	CcSEcCtD
Prazosin—Vomiting—Doxorubicin—bone cancer	0.000136	0.00267	CcSEcCtD
Prazosin—Rash—Doxorubicin—bone cancer	0.000135	0.00265	CcSEcCtD
Prazosin—Dermatitis—Doxorubicin—bone cancer	0.000135	0.00265	CcSEcCtD
Prazosin—Headache—Doxorubicin—bone cancer	0.000134	0.00263	CcSEcCtD
Prazosin—Nausea—Doxorubicin—bone cancer	0.000127	0.0025	CcSEcCtD
Prazosin—HTR1A—GPCR downstream signaling—GRM1—bone cancer	0.000116	0.00123	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—GRM4—bone cancer	0.000116	0.00122	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—RGS1—bone cancer	0.000116	0.00122	CbGpPWpGaD
Prazosin—SLC22A1—Transmission across Chemical Synapses—BRAF—bone cancer	0.000114	0.00121	CbGpPWpGaD
Prazosin—ADRA2A—GPCR ligand binding—SMO—bone cancer	0.000113	0.0012	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—GRM4—bone cancer	0.000113	0.0012	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—RGS1—bone cancer	0.000113	0.0012	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—IL3—bone cancer	0.000111	0.00117	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—GRM1—bone cancer	0.00011	0.00117	CbGpPWpGaD
Prazosin—HTR1A—SIDS Susceptibility Pathways—JUN—bone cancer	0.00011	0.00116	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—GRM1—bone cancer	0.000109	0.00115	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000106	0.00112	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000106	0.00112	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—GRM1—bone cancer	0.000105	0.00111	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—GRM4—bone cancer	0.000105	0.00111	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—RGS1—bone cancer	0.000105	0.00111	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—NDUFA12—bone cancer	0.000104	0.0011	CbGpPWpGaD
Prazosin—SLC22A2—Transmission across Chemical Synapses—MDM2—bone cancer	0.000103	0.00109	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—RGS1—bone cancer	0.000103	0.00109	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—GRM4—bone cancer	0.000103	0.00109	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—SPARC—bone cancer	0.000101	0.00107	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—GRM1—bone cancer	0.0001	0.00106	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—GNA11—bone cancer	0.0001	0.00106	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—SMO—bone cancer	9.93e-05	0.00105	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—NT5C3A—bone cancer	9.91e-05	0.00105	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—GRM1—bone cancer	9.8e-05	0.00104	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—GRM4—bone cancer	9.61e-05	0.00102	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—RGS1—bone cancer	9.61e-05	0.00102	CbGpPWpGaD
Prazosin—SLC22A1—Transmission across Chemical Synapses—MDM2—bone cancer	9.59e-05	0.00102	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—GRM4—bone cancer	9.53e-05	0.00101	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—RGS1—bone cancer	9.53e-05	0.00101	CbGpPWpGaD
Prazosin—SLC22A2—Neuronal System—BRAF—bone cancer	9.41e-05	0.000996	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—GNA11—bone cancer	9.28e-05	0.000983	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	9.13e-05	0.000967	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—GRM1—bone cancer	9.1e-05	0.000964	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—GNA11—bone cancer	9.09e-05	0.000962	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—IL3—bone cancer	9.07e-05	0.000961	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—GRM1—bone cancer	8.9e-05	0.000942	CbGpPWpGaD
Prazosin—SLC22A1—Neuronal System—BRAF—bone cancer	8.77e-05	0.000929	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—ENO2—bone cancer	8.76e-05	0.000928	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—NT5C3A—bone cancer	8.58e-05	0.000909	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—GNA11—bone cancer	8.56e-05	0.000907	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—SMO—bone cancer	8.5e-05	0.000901	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—IL3—bone cancer	8.42e-05	0.000891	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—GRM1—bone cancer	8.33e-05	0.000882	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—NDUFA12—bone cancer	8.27e-05	0.000876	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—GRM1—bone cancer	8.27e-05	0.000876	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—IL3—bone cancer	8.24e-05	0.000872	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—GRM4—bone cancer	8.22e-05	0.000871	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—RGS1—bone cancer	8.22e-05	0.000871	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—DHFR—bone cancer	8.13e-05	0.000861	CbGpPWpGaD
Prazosin—SLC22A2—Neuronal System—MDM2—bone cancer	7.88e-05	0.000835	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	7.87e-05	0.000833	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—GNA11—bone cancer	7.78e-05	0.000824	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—IL3—bone cancer	7.76e-05	0.000822	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—GNA11—bone cancer	7.73e-05	0.000819	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—SMO—bone cancer	7.68e-05	0.000813	CbGpPWpGaD
Prazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	7.65e-05	0.00081	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—GNA11—bone cancer	7.59e-05	0.000804	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—GNA11—bone cancer	7.46e-05	0.00079	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—GRM4—bone cancer	7.42e-05	0.000786	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—RGS1—bone cancer	7.42e-05	0.000786	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—SMO—bone cancer	7.41e-05	0.000785	CbGpPWpGaD
Prazosin—SLC22A1—Neuronal System—MDM2—bone cancer	7.35e-05	0.000778	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—PLAU—bone cancer	7.28e-05	0.000771	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—RGS1—bone cancer	7.17e-05	0.000759	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—GRM4—bone cancer	7.17e-05	0.000759	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—GRM1—bone cancer	7.13e-05	0.000755	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—GNA11—bone cancer	7.11e-05	0.000753	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—SMO—bone cancer	7.06e-05	0.000747	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—IL3—bone cancer	7.05e-05	0.000747	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—GNA11—bone cancer	7.02e-05	0.000744	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—IL3—bone cancer	7.01e-05	0.000742	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—CYP3A4—bone cancer	6.89e-05	0.000729	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—NT5C3A—bone cancer	6.85e-05	0.000726	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—RGS1—bone cancer	6.82e-05	0.000723	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—GRM4—bone cancer	6.82e-05	0.000723	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—GNA11—bone cancer	6.78e-05	0.000718	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—IL3—bone cancer	6.77e-05	0.000717	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—GNA11—bone cancer	6.45e-05	0.000684	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—IL3—bone cancer	6.44e-05	0.000682	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—GRM1—bone cancer	6.44e-05	0.000682	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—IL3—bone cancer	6.37e-05	0.000674	CbGpPWpGaD
Prazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	6.35e-05	0.000673	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—GNA11—bone cancer	6.31e-05	0.000669	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—SMO—bone cancer	6.27e-05	0.000664	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—GRM1—bone cancer	6.21e-05	0.000658	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—IL3—bone cancer	6.14e-05	0.000651	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—RGS1—bone cancer	6.06e-05	0.000642	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—GRM4—bone cancer	6.06e-05	0.000642	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—GRM1—bone cancer	5.92e-05	0.000627	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—GSTP1—bone cancer	5.89e-05	0.000624	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—SMO—bone cancer	5.87e-05	0.000622	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—GNA11—bone cancer	5.87e-05	0.000621	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—IL3—bone cancer	5.85e-05	0.00062	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	5.83e-05	0.000618	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—SMO—bone cancer	5.82e-05	0.000617	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—GNA11—bone cancer	5.73e-05	0.000607	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—IL3—bone cancer	5.72e-05	0.000606	CbGpPWpGaD
Prazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	5.64e-05	0.000598	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—RGS1—bone cancer	5.63e-05	0.000597	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—GRM4—bone cancer	5.63e-05	0.000597	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	5.62e-05	0.000595	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—ENO2—bone cancer	5.55e-05	0.000588	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—PLAU—bone cancer	5.52e-05	0.000585	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—ENO2—bone cancer	5.49e-05	0.000582	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—GNA11—bone cancer	5.37e-05	0.000568	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—GNA11—bone cancer	5.33e-05	0.000564	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—IL3—bone cancer	5.32e-05	0.000563	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—GRM1—bone cancer	5.26e-05	0.000557	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—IL3—bone cancer	5.2e-05	0.000551	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—DHFR—bone cancer	5.15e-05	0.000545	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—ENO2—bone cancer	5.12e-05	0.000542	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—DHFR—bone cancer	5.1e-05	0.00054	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	5.07e-05	0.000537	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—SMO—bone cancer	5.02e-05	0.000532	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—ATF1—bone cancer	4.99e-05	0.000529	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—GRM1—bone cancer	4.88e-05	0.000517	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—IL3—bone cancer	4.87e-05	0.000515	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—IL3—bone cancer	4.83e-05	0.000511	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—GNA11—bone cancer	4.81e-05	0.00051	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—GNA11—bone cancer	4.76e-05	0.000505	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—DHFR—bone cancer	4.75e-05	0.000503	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—GNA11—bone cancer	4.59e-05	0.000487	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—SMO—bone cancer	4.53e-05	0.00048	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—GNA11—bone cancer	4.44e-05	0.00047	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—SMO—bone cancer	4.38e-05	0.000464	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—CYP3A4—bone cancer	4.36e-05	0.000462	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—ENO2—bone cancer	4.34e-05	0.00046	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—CYP3A4—bone cancer	4.32e-05	0.000457	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—ATF1—bone cancer	4.27e-05	0.000452	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—SMO—bone cancer	4.17e-05	0.000442	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—IL3—bone cancer	4.16e-05	0.000441	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—TGFBR2—bone cancer	4.16e-05	0.000441	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—GNA11—bone cancer	4.15e-05	0.000439	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—DHFR—bone cancer	4.03e-05	0.000426	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—CYP3A4—bone cancer	4.03e-05	0.000426	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—GNA11—bone cancer	4e-05	0.000424	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	3.98e-05	0.000422	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—IGF1R—bone cancer	3.92e-05	0.000415	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—ATF1—bone cancer	3.86e-05	0.000408	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—GNA11—bone cancer	3.81e-05	0.000404	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—GNA11—bone cancer	3.76e-05	0.000399	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—IL3—bone cancer	3.76e-05	0.000398	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—ENO2—bone cancer	3.76e-05	0.000398	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—GSTP1—bone cancer	3.73e-05	0.000395	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—ATF1—bone cancer	3.72e-05	0.000394	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—SMO—bone cancer	3.7e-05	0.000392	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—GSTP1—bone cancer	3.69e-05	0.000391	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—IL3—bone cancer	3.63e-05	0.000384	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—TGFBR2—bone cancer	3.56e-05	0.000377	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—ATF1—bone cancer	3.54e-05	0.000375	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—DHFR—bone cancer	3.49e-05	0.000369	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IL3—bone cancer	3.46e-05	0.000366	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—GSTP1—bone cancer	3.44e-05	0.000365	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—SMO—bone cancer	3.44e-05	0.000364	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—CYP3A4—bone cancer	3.41e-05	0.000361	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—GNA11—bone cancer	3.39e-05	0.000359	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—IGF1R—bone cancer	3.35e-05	0.000355	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	3.35e-05	0.000354	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—GNA11—bone cancer	3.26e-05	0.000345	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—TGFBR2—bone cancer	3.22e-05	0.000341	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—ATF1—bone cancer	3.15e-05	0.000333	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—GNA11—bone cancer	3.15e-05	0.000333	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—TGFBR2—bone cancer	3.1e-05	0.000329	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IL3—bone cancer	3.07e-05	0.000325	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—PTGS2—bone cancer	3.05e-05	0.000323	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—IGF1R—bone cancer	3.03e-05	0.00032	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—ENO2—bone cancer	3e-05	0.000318	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—TGFBR2—bone cancer	2.96e-05	0.000313	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—CYP3A4—bone cancer	2.95e-05	0.000313	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.94e-05	0.000311	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—ATF1—bone cancer	2.93e-05	0.00031	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—TP53—bone cancer	2.92e-05	0.00031	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—IGF1R—bone cancer	2.92e-05	0.000309	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—GSTP1—bone cancer	2.92e-05	0.000309	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IL3—bone cancer	2.85e-05	0.000302	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—KIT—bone cancer	2.84e-05	0.000301	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—DHFR—bone cancer	2.78e-05	0.000295	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IGF1R—bone cancer	2.78e-05	0.000295	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—BRAF—bone cancer	2.67e-05	0.000283	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—TGFBR2—bone cancer	2.63e-05	0.000278	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—GNA11—bone cancer	2.6e-05	0.000276	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—EGFR—bone cancer	2.59e-05	0.000274	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—GSTP1—bone cancer	2.53e-05	0.000268	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IGF1R—bone cancer	2.47e-05	0.000262	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—TGFBR2—bone cancer	2.44e-05	0.000258	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—KIT—bone cancer	2.43e-05	0.000257	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—CYP3A4—bone cancer	2.36e-05	0.00025	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IGF1R—bone cancer	2.3e-05	0.000243	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—BRAF—bone cancer	2.28e-05	0.000242	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—MDM2—bone cancer	2.24e-05	0.000237	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—TP53—bone cancer	2.22e-05	0.000235	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—EGFR—bone cancer	2.21e-05	0.000235	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—KIT—bone cancer	2.19e-05	0.000232	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—KIT—bone cancer	2.12e-05	0.000224	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—BRAF—bone cancer	2.06e-05	0.000218	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—GSTP1—bone cancer	2.02e-05	0.000214	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—KIT—bone cancer	2.02e-05	0.000214	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—EGFR—bone cancer	2e-05	0.000212	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—BRAF—bone cancer	1.99e-05	0.000211	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—JUN—bone cancer	1.94e-05	0.000206	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—PTGS2—bone cancer	1.93e-05	0.000205	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—EGFR—bone cancer	1.93e-05	0.000204	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—MDM2—bone cancer	1.91e-05	0.000203	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—PTGS2—bone cancer	1.91e-05	0.000203	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—BRAF—bone cancer	1.9e-05	0.000201	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—MMP9—bone cancer	1.89e-05	0.0002	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—EGFR—bone cancer	1.84e-05	0.000195	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—KIT—bone cancer	1.79e-05	0.00019	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—PTGS2—bone cancer	1.78e-05	0.000189	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—MDM2—bone cancer	1.73e-05	0.000183	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—BRAF—bone cancer	1.68e-05	0.000178	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—MDM2—bone cancer	1.67e-05	0.000177	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—KIT—bone cancer	1.66e-05	0.000176	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—JUN—bone cancer	1.66e-05	0.000176	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—EGFR—bone cancer	1.63e-05	0.000173	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—MMP9—bone cancer	1.62e-05	0.000171	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—MDM2—bone cancer	1.59e-05	0.000168	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—BRAF—bone cancer	1.56e-05	0.000166	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—EGFR—bone cancer	1.53e-05	0.000162	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—EGFR—bone cancer	1.52e-05	0.000161	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—PTGS2—bone cancer	1.51e-05	0.00016	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—JUN—bone cancer	1.5e-05	0.000159	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—MMP9—bone cancer	1.46e-05	0.000155	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—JUN—bone cancer	1.45e-05	0.000154	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—MDM2—bone cancer	1.41e-05	0.000149	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—MMP9—bone cancer	1.41e-05	0.000149	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—JUN—bone cancer	1.38e-05	0.000146	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—MMP9—bone cancer	1.34e-05	0.000142	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—MDM2—bone cancer	1.31e-05	0.000139	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—PTGS2—bone cancer	1.31e-05	0.000139	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—EGFR—bone cancer	1.31e-05	0.000139	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—TP53—bone cancer	1.28e-05	0.000136	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—JUN—bone cancer	1.23e-05	0.00013	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—MMP9—bone cancer	1.19e-05	0.000126	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—EGFR—bone cancer	1.18e-05	0.000125	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—EGFR—bone cancer	1.14e-05	0.000121	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—JUN—bone cancer	1.14e-05	0.000121	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—MMP9—bone cancer	1.11e-05	0.000117	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—TP53—bone cancer	1.1e-05	0.000116	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—EGFR—bone cancer	1.09e-05	0.000115	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PTGS2—bone cancer	1.05e-05	0.000111	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—TP53—bone cancer	9.92e-06	0.000105	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—EGFR—bone cancer	9.64e-06	0.000102	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—TP53—bone cancer	9.57e-06	0.000101	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—TP53—bone cancer	9.12e-06	9.66e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—EGFR—bone cancer	8.96e-06	9.49e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—TP53—bone cancer	8.1e-06	8.58e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—TP53—bone cancer	7.52e-06	7.97e-05	CbGpPWpGaD
